Keras/TensorFlow in Drug Design for Immunity Disorders.

Dragan, Paulina; Joshi, Kavita; Atzei, Alessandro; Latek, Dorota

Dragan, Paulina; Joshi, Kavita; Atzei, Alessandro; Latek, Dorota.

Afiliação

Dragan P; Faculty of Chemistry, University of Warsaw, Pasteura 1, 02-903 Warsaw, Poland.
Joshi K; Faculty of Chemistry, University of Warsaw, Pasteura 1, 02-903 Warsaw, Poland.
Atzei A; Faculty of Chemistry, University of Warsaw, Pasteura 1, 02-903 Warsaw, Poland.
Latek D; Department of Life and Environmental Science, Food Toxicology Unit, University of Cagliari, University Campus of Monserrato, SS 554, 09042 Cagliari, Italy.

Int J Mol Sci ; 24(19)2023 Oct 09.

Article em En | MEDLINE | ID: mdl-37834457

Assuntos

Quimiocinas; Citocinas; Quimiocinas/metabolismo; Citocinas/farmacologia; Receptores de Quimiocinas/metabolismo; Quimiotaxia; Desenho de Fármacos; Receptores CXCR3

Palavras-chave

CCR2; CCR3; CXCR3; G protein-coupled receptors; Keras; TensorFlow; cancer; chemokine receptors; immunity disorders; inflammation; molecular dynamics; neural network; structure-based virtual screening

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Citocinas / Quimiocinas Idioma: En Revista: Int J Mol Sci Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Polônia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google